Dynacure develops new treatments for patients suffering from serious orphan disorders. The first drug discovery program of Dynacure focuses on Centronuclear Myo...
| Website | http://www.dynacure.fr |
| Revenue | $7.4 million |
| Employees | 6 (0 on RocketReach) |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Keywords | Orphan Drug Development, Rare Disease Therapies, New Therapies, Clinical Trials, Pharmaceutical Research, Biotechnology, Genetic Disorders, Medical Research, Patient Care, Health Solutions, Disease Treatment, Drug Development, Healthcare |
| Competitors | Amgen, Takeda, Vertex Pharmaceuticals, BioMarin Pharmaceutical Inc., アステラス製薬（株）, Sobi - Swedish Orphan Biovitrum AB (publ), Genzyme Europe B.V., bluebird bio, MorphoSys, Sarepta Therapeutics, Inc. +44 more (view full list) |
Looking for a particular Dynacure employee's phone or email?
Dynacure Questions
The Dynacure annual revenue was $7.4 million in 2026.
Dynacure is based in Strasbourg, Grand-Est.
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5
free lookups.
Search the #1
Contact Database
Get contact details of over 700M profiles across 60M
companies – all with industry-leading accuracy. Sales and Recruiter users, try out our
Email Finder Extension.
Use our
AI-Powered
Email Finder
Find business and personal emails and mobile phone numbers
with exclusive coverage across niche job titles, industries, and more
for unparalleled targeting. Also
available via our
Contact Data API.
G2Crowd Trusted
300K+
Plugin Users
